LENZ Therapeutics (LENZ) Balance Sheet: Assets & Liabilities

LENZ Therapeutics (LENZ) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), LENZ Therapeutics reported total assets of $305.88M and total liabilities of $21.54M. Shareholders' equity was $284.34M, up 39.3% from $204.08M a year earlier. Total debt stood at $815.00K against $292.35M in cash and short-term investments, a net cash position of $291.53M. That puts debt-to-equity at 0.00, compared with 0.01 a year earlier.

LENZ Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for LENZ Therapeutics, Inc. (LENZ) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	25.18	20.16	35.14	44.44	18.31	19.82	0.01
Short-Term Investments	267.17	188.87	30.65	220.50	0.00	0.00	0.00
Cash & Short-Term Investments	292.35	209.03	65.79	44.44	18.31	19.82	0.01
Accounts Receivable	0.33	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	2.94	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	5.80	2.89	1.45	7.14	0.02	1.29	0.00
Total Current Assets	301.41	211.92	67.24	46.64	18.32	21.10	0.01
Non-Current Assets
Property, Plant & Equipment (Net)	1.92	1.99	0.37	28.21	0.01	1.46	0.00
Long-Term Investments	0.00	0.00	0.00	15.32	0.00	0.00	0.00
Other Non-Current Assets	2.54	1.40	2.76	3.01	0.00	0.00	0.00
Total Non-Current Assets	4.46	3.39	3.13	0.31	0.01	1.46	0.00
Total Assets	305.88	215.30	70.38	46.95	18.34	22.56	0.01
Current Liabilities
Accounts Payable	4.17	4.26	5.71	2.61	0.46	0.63	0.00
Short-Term Debt	0.47	0.57	0.14	0.10	0.00	0.00	2.21
Accrued Liabilities	17.02	6.15	12.67	6.39	0.79	-	-
Other Current Liabilities	16.56	5.58	12.67	4.29	0.79	31.42	0.02
Total Current Liabilities	21.19	10.41	18.51	13.04	1.25	32.05	2.22
Non-Current Liabilities
Long-Term Debt	0.35	0.81	0.19	0.15	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.12	10.82	31.30	0.32	0.00
Total Non-Current Liabilities	0.35	0.81	144.57	12.57	31.30	0.32	0.00
Total Liabilities	21.54	11.22	163.09	9.71	32.55	32.36	2.22
Stockholders' Equity
Common Stock	0.00	0.00	0.01	0.00	0.00	0.00	0.00
Retained Earnings	-227.14	-145.01	-95.25	-242.40	-14.47	-70.59	-2.22
Accumulated Other Comprehensive Income	0.24	0.20	0.01	-1.05	0.00	0.00	0.00
Additional Paid-in Capital	511.24	348.90	2.52	1.10	0.25	5.18	0.00
Shares Outstanding	31.34	27.52	25.53	25.53	25.53	-	-
Total Stockholders' Equity	284.34	204.08	-92.71	37.24	-14.21	-9.80	-2.22
Total Liabilities & Equity	305.88	215.30	70.38	46.95	18.34	22.56	0.01

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About LENZ Therapeutics Balance Sheet

How much debt does LENZ Therapeutics have?

LENZ Therapeutics had total debt of $815.00K as of Dec 31, 2025, against $292.35M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $1.38M a year earlier.

What are LENZ Therapeutics's total assets?

LENZ Therapeutics reported total assets of $305.88M as of Dec 31, 2025, up 42.1% from $215.30M a year earlier. Total liabilities were $21.54M.

What is LENZ Therapeutics's shareholders' equity?

LENZ Therapeutics's shareholders' equity was $284.34M as of Dec 31, 2025, or about $9.07 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition